Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-001710
Filing Date
2018-02-20
Accepted
2018-02-20 12:40:11
Documents
54
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT cantabio10-q.htm 10-Q 391553
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-1.htm EX-31.1 13468
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-2.htm EX-31.2 13531
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32-1.htm EX-32.1 5047
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32-2.htm EX-32.2 5522
  Complete submission text file 0001654954-18-001710.txt   1625742

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctbo-20171231.xml EX-101.INS 243242
7 XBRL TAXONOMY EXTENSION SCHEMA ctbo-20171231.xsd EX-101.SCH 24924
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctbo-20171231_cal.xml EX-101.CAL 12954
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctbo-20171231_def.xml EX-101.DEF 44995
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctbo-20171231_lab.xml EX-101.LAB 101032
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctbo-20171231_pre.xml EX-101.PRE 104733
Mailing Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54906 | Film No.: 18623842
SIC: 2834 Pharmaceutical Preparations